Drugs & Targets FDA grants accelerated approval to zenocutuzumab-zbco for NSCLC and pancreatic adenocarcinoma December 06, 2024Vol.50 No.45
Clinical Roundup NCCN updates CML treatment guidelines following FDA approval of Scemblix for newly diagnosed patients November 22, 2024Vol.50 No.44
Drugs & Targets FDA approves new alternative standard related to mammography report assessments November 22, 2024Vol.50 No.44
Drugs & Targets FDA approves revumenib for r/r acute leukemia with a KMT2A translocation November 22, 2024Vol.50 No.44
Drugs & Targets FDA approves first companion diagnostic for lung cancer drug November 22, 2024Vol.50 No.44
Regulatory News Ready or not, AI-based decision support tools are entering oncology clinicsRegulators and health systems must adapt November 15, 2024Vol.50 No.43By McKenzie Prillaman
Drugs & Targets FDA approves Aucatzyl for adults with r/r B-cell precursor ALL November 15, 2024Vol.50 No.43
Drugs & Targets FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients November 08, 2024Vol.50 No.42
